A preliminary metabolites identification of a novel compound with β-adrenolytic activity.

Published in: Pharmacological reports : PR (2021)

(RS)-9 was extensively metabolised to several phase I and II metabolites, and renal excretion was a minor route in its elimination.

Keyphrases